News
Public · Published
Lupin shares in focus after US sales beat expectations but profitability impacted
Lupin reported September-quarter revenue of ₹7,827.26 crore, up 11% year on year but down 5.4% from the previous quarter. EBITDA, a measure of operating earnings, fell 13% year on year, and net profit fell 22%. US sales rose 9.3% year on year, though they declined sequentially.
Published:
Updated:
What happened
Lupin reported September-quarter revenue of ₹7,827.26 crore, up 11% year on year but down 5.4% from the previous quarter. EBITDA, a measure of operating earnings, fell 13% year on year, and net profit fell 22%. US sales rose 9.3% year on year, though they declined sequentially.
Confirmed
Global impact / market context
Higher revenue and US sales show growth against the year-ago quarter, but lower operating earnings and profit point to pressure on costs or the mix of sales. If that pressure persists, it could limit cash available for investment even as sales expand.
Analyst inference
Lupin’s results were slightly ahead of market estimates, including operating earnings and profit, while both remained below year-ago levels. This creates a mixed signal: the beat may support expectations, but falling profit per sale and sequential declines could temper confidence in sustained growth.
Analyst inference
What to watch
- Check upcoming results for whether operating earnings and net profit stabilize or continue falling, since persistent declines could restrict funds available for investment and other company needs. Analyst inference
- Watch whether US sales recover from their sequential decline; the region contributed 39% of overall sales, so continued weakness could weigh on total revenue. Analyst inference
- Compare future operating profit per sale with the reported 26.1% EBITDA margin, which measures operating earnings as a share of revenue, to assess profitability. Analyst inference
Evidence
- Original source link unavailable